Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$532K Sell
14,243
-3,455
-20% -$145K ﹤0.01% 1627
2026
Q1
$867K Sell
17,698
-45,551
-72% -$2.39M ﹤0.01% 1332
2025
Q4
$3.35M Buy
63,249
+52,885
+510% +$3.08M ﹤0.01% 1087
2025
Q3
$627K Buy
10,364
+583
+6% +$33.6K ﹤0.01% 1266
2025
Q2
$518K Buy
9,781
+9,722
+16,478% +$416K ﹤0.01% 1366
2025
Q1
$1.91K Sell
59
-8,580
-99% -$318K ﹤0.01% 1968
2024
Q4
$330K Buy
+8,639
New +$304K ﹤0.01% 1646

Other funds holding CALX

Amundi's CALX Position: Q2 2026 in Review

Amundi reduced its Calix (CALX) stake by 20% in Q2 2026, selling an estimated $145K and leaving 14,243 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #1627.

Amundi first reported a position in CALX in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.35M in Q4 2025. 285 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • Amundi held 14,243 shares of Calix worth $532K as of Q2 2026.
  • Amundi sold 3,455 Calix shares in Q2 2026, an estimated $145K.
  • Calix made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1627 holding.
  • Amundi first reported a position in Calix in Q4 2024 and has held it in 7 quarters since.
  • Amundi's Calix position peaked at $3.35M in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.